22
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: not found
      • Article: not found

      A deviation from standard design? Clinical trials, research ethics committees, and the regulatory co-construction of organizational deviance

      Social Studies of Science
      SAGE Publications

      Read this article at

      ScienceOpenPublisher
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Related collections

          Most cited references47

          • Record: found
          • Abstract: not found
          • Article: not found

          Knowledge flows through informal contacts in industrial clusters: myth or reality?

            Bookmark
            • Record: found
            • Abstract: not found
            • Book: not found

            Friendly Fire

              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              "Cytokine storm" in the phase I trial of monoclonal antibody TGN1412: better understanding the causes to improve preclinical testing of immunotherapeutics.

              The CD28-specific mAb TGN1412 rapidly caused a life-threatening "cytokine storm" in all six healthy volunteers in the Phase I clinical trial of this superagonist, signaling a failure of preclinical safety testing. We report novel in vitro procedures in which TGN1412, immobilized in various ways, is presented to human white blood cells in a manner that stimulates the striking release of cytokines and profound lymphocyte proliferation that occurred in vivo in humans. The novel procedures would have predicted the toxicity of this superagonist and are now being applied to emerging immunotherapeutics and to other therapeutics that have the potential to act upon the immune system. Data from these novel procedures, along with data from in vitro and in vivo studies in nonhuman primates, suggest that the dose of TGN1412 given to human volunteers was close to the maximum immunostimulatory dose and that TGN1412 is not a superagonist in nonhuman primates.
                Bookmark

                Author and article information

                Journal
                Social Studies of Science
                Soc Stud Sci
                SAGE Publications
                0306-3127
                1460-3659
                September 25 2013
                October 21 2013
                : 44
                : 1
                : 59-81
                Article
                10.1177/0306312713506141
                f95c5880-d391-4638-add7-672f5351179b
                © 2013
                History

                Comments

                Comment on this article